A pilot study of the effect of oral curcumin on lymphocyte count in patients with clinical stage 0/1 chronic lymphocytic leukemia.

Completed

• Conditions: stage 0/1 chronic lymphocytic leukemia; Cancer - Leukaemia - Chronic leukaemia; Alternative and Complementary Medicine - Herbal remedies

• Registration Number: ACTRN12615000487516
• Lead Sponsor: Southern Sydney Haematology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Male or female patients over the age of 40 who have been diagnosed with stage 0/1 chronic lymphocytic leukemia (absolute lymphocyte count > 20x10 (9)lymphocytes/L).

Exclusion Criteria

1)Patients who are being actively treated.
2)Requirement for major surgery
3) Patients with diabetes
4) Patients on warfarin
5) Patients with GORD

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A change in absolute lymphocyte count as assessed by serum assay. [assessment will be made at baseline, 2, 4 and 6 months]

Secondary Outcome Measures

Name	Time	Method
a change in surface leukocyte markers as determined by blood tests.[assessment will be made at baseline, 2, 4 and 6 months. ];CRP and ESR as determined by blood tests[baseline, 2, 4 and 6 months];liver function as determined by blood tests[baseline, 2, 4 and 6 months]